描述

A study by StrategyHelix indicates that the global companion animal vaccine market is expected to increase by US$ 1,247.9 百万来自 2022 到 2028, 复合年增长率为 5.6% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for companion animal vaccine. The global companion animal vaccine market is segmented on the basis of technology, animal type, 和地区. Based on technology, the global companion animal vaccine market is categorized into attenuated vaccines (LAV), inactivated vaccines, recombinant vaccines, toxoid vaccines, 其他的. The attenuated vaccines segment captured the largest share of the market in 2021. 根据动物类型, the global companion animal vaccine market has been segmented into cats, 小狗, 其他的. The dogs segment held the largest share of the global companion animal vaccine market in 2021 预计在预测期内将持有其份额. 从地理上来说, the global companion animal vaccine market has been segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排). 在 2021, North America made up the largest share of revenue generated by the companion animal vaccine market.

The global companion animal vaccine market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Bioveta a.s., Boehringer Ingelheim International GmbH, Durvet Inc., Elanco 动物保健公司, HIPRA S.A., Indian Immunologicals Ltd (IIL), Inner Mongolia Jinyu Group Co. 有限公司, 默克 & 钴. 公司, Pulike Biological Engineering Inc., Tianjin Ringpu Bio-technology Co. 有限公司, Virbac New Zealand Ltd., 硕腾公司. Competitive landscape gives a description of the competitive nature of the global companion animal vaccine market and a description of the leading companies. 确定了近年来塑造市场的关键金融交易.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the companion animal vaccine market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

技术: attenuated vaccines (LAV), inactivated vaccines, recombinant vaccines, toxoid vaccines, 其他的
动物类型: 猫, 小狗, 其他的
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028
提到的公司: Bioveta a.s., Boehringer Ingelheim International GmbH, Durvet Inc., Elanco 动物保健公司, HIPRA S.A., Indian Immunologicals Ltd (IIL), Inner Mongolia Jinyu Group Co. 有限公司, 默克 & 钴. 公司, Pulike Biological Engineering Inc., Tianjin Ringpu Bio-technology Co. 有限公司, Virbac New Zealand Ltd., 硕腾公司.

利益相关者的主要好处

– Get a comprehensive picture of the global companion animal vaccine market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Companion animal vaccine market overview
部分 3. 按技术划分的市场细分
– Attenuated vaccines (LAV)
– Inactivated vaccines
– Recombinant vaccines
– Toxoid vaccines
– 其他的
部分 4. Market breakdown by animal type
– 猫
– 小狗
– 其他的
部分 5. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 6. 重点企业
– Bioveta a.s.
– Boehringer Ingelheim International GmbH
– Durvet, 公司.
– Elanco 动物保健公司
– HIPRA, 南非.
– Indian Immunologicals Ltd (IIL)
– Inner Mongolia Jinyu Group Co., 有限公司.
– 默克 & 公司。, 公司.
– Pulike Biological Engineering, 公司.
– Tianjin Ringpu Bio-technology Co., 有限公司.
– Virbac New Zealand Ltd.
– 硕腾公司.
关于StrategyHelix
免责声明